Finnrick - Ensuring a Safer and More Transparent Supply Chain
GLP Keep Body Peptide

GLP Keep Body Peptide

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from GLP Keep Body Peptide between 1 Mar 2026 and 27 May 2026. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).

Finnrick Rating™
Tentative Rating
GLP Keep Body Peptide
Tirzepatide
Tested 5 Samples
Last test 27 May 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from GLP Keep Body Peptide

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.2MIN3.9MAX9.7

Last

27 May 2026

First

1 Mar 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
27 May 2026View5.010mg7.66mg-23.4%99.90%(no batch ID)No label / Silver crimp / Orange capLab EPublic
28 Apr 2026View8.030mg29.7mg-1.0%99.90%(no batch ID)No Label / Silver Crimp / Gray CapLab EPublic
18 Mar 2026View9.715mg15.9mg+6.0%99.90%TR15-0AAA1White Label / Silver Crimp / Yellow CapLab EPublic
4 Mar 2026View3.930mg18.6mg-38.0%98.15%01222026(no data)Lab EPublic
1 Mar 2026View4.530mg17.3mg-42.3%99.80%(no batch ID)White Label / Silver Crimp / Yellow CapLab GPublic
Test my peptides for free